MAIN PROGRAM

THURSDAY, MARCH 19TH 2026

Welcome

Opening remarks day 1: Philipp Steven

90 min.          
Session 1: Progress in understanding ocular GVHD pathogenesis

90 min.          
Session 2: Early detection and/or prophylaxis of ocular GVHD

Lunch break

Keynote lecture: No systemic but organ GVHD – the new normal?

90 min.          
Session 3: Novel targets and therapies for ocular GVHD

90 min.          
Session 4: Surgical/advanced management of complications of ocular GVHD

PARALLEL PROGRAM 
March 19th 2026

One day educational course (physicians), and short course for nurses: special-care nursing

45 min. 
1. Allogeneic hematopoetic stem cell transplantation

45 min.          
2. Graft-versus-host disease – general and organ specific (overview)

2x 45 min.      
3. Post-transplant patient care

45 min.          
4. GVHD prophylaxs

Keynote attendance

45 min.          
5. Ocular GVHD

45 min.
6. Skin GVHD

45 min.
7. Lung and intensinal GVHD

45 min.
8. Psycho-Oncology

MAIN PROGRAM

FRIDAY, MARCH 20TH 2026

Opening remarks day 2: Christof Scheid

Keynote Nr. 2 GVHD, do we need it?

90 min.          
Session 5: Interplay between systemic and organ-specific GVHD

90 min.          
Session 6: Skin GVHD

90 min.          
Session 7: Clinical trials, drug approval and the patient perspective

90 min.          
Session 8: Ocular toxicities beyond GVHD – Bispecifics, ADCs and CAR-T

Wrap up: What’s new, what have we learned.

Farewell comments – Philipp Steven and Christof Scheid

PARALLEL PROGRAM 
March 20th2026

One day educational course (physicians),
and short course for nurses: special-care nursing

45 min.          
1. Allogeneic hematopoetic stem cell transplantation

45 min.          
2. Graft-versus-host disease – general

45 min.          
3. Post-transplant patient care

45 min.          
4. GVHD prophylaxis

Keynote attendance

45 min.          
5. Ocular GVHD

45 min.          
6. Skin GVHD

45 min.          
7. Lung and intestinal GVHD

45 min.          
8. Psycho-oncology